# OnCo record puma-biotechnology (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/puma-biotechnology/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "puma-biotechnology" ;
  schema:name "Puma Biotechnology"@en ;
  schema:description "Puma Biotechnology developed neratinib (Nerlynx), the extended-adjuvant HER2 pill."@en ;
  schema:url <https://onco.cc/companies/puma-biotechnology/>, <https://www.pumabiotechnology.com> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://www.pumabiotechnology.com> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/breast-her2-positive/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:drugs <https://onco.cc/drugs/neratinib/> ;
  onco:trials <https://onco.cc/trials/nct06095505/>, <https://onco.cc/trials/nct06369285/> .